These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20375073)

  • 21. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of E-cadherin controls endometrial receptivity.
    Rahnama F; Thompson B; Steiner M; Shafiei F; Lobie PE; Mitchell MD
    Endocrinology; 2009 Mar; 150(3):1466-72. PubMed ID: 18974268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
    Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
    Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
    Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
    Chang HW; Chow V; Lam KY; Wei WI; Yuen A
    Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
    Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
    Mei FC; Young TW; Liu J; Cheng X
    FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
    Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
    Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aberrant methylation of T-cadherin gene in human esophageal carcinoma cells].
    Jing Z; Zou CL; Li G; Deng X; Wu SX
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(37):2653-6. PubMed ID: 22321935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells.
    Schreiber SC; Giehl K; Kastilan C; Hasel C; Mühlenhoff M; Adler G; Wedlich D; Menke A
    Gastroenterology; 2008 May; 134(5):1555-66. PubMed ID: 18384787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
    Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
    Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
    Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
    Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.
    Lee JO; Kwun HJ; Jung JK; Choi KH; Min DS; Jang KL
    Oncogene; 2005 Oct; 24(44):6617-25. PubMed ID: 16007161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.